Showing results (21-30 of 37) with videos related to
Sort By:
Pageof 4
Addiction (Abingdon, England)|February 23, 2022
Comparative efficacy and safety of pharmacotherapies for alcohol withdrawal: a systematic review and network meta-analysisAnees Bahji, Paxton Bach, Marlon Danilewitz, et al.Annals of the New York Academy of Sciences|October 12, 2012
The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patientsTerry Treadwell, Hynda K Kleinman, David Crockford, et al.Addiction (Abingdon, England)|September 28, 2023
Cannabis use disorder and adverse cardiovascular outcomes: A population-based retrospective cohort analysis of adults from Alberta, CanadaAnees Bahji, Josh Hathaway, Denise Adams, et al.Annals of the New York Academy of Sciences|June 12, 2010
Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4Steven P Dunn, David G Heidemann, Christopher Y C Chow, et al.Psychiatric Research and Clinical Practice|December 13, 2021
Strategies to aid self-isolation and quarantine for individuals with severe and persistent mental illness during the COVID-19 pandemic: A systematic reviewAnees Bahji, Paxton Bach, Marlon Danilewitz, et al.Scientific Reports|October 23, 2020
Chronic bryostatin-1 rescues autistic and cognitive phenotypes in the fragile X micePatricia Cogram, Daniel L Alkon, David Crockford, et al.Journal of Alzheimer'S Disease : JAD|December 12, 2018
A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's DiseaseMartin R Farlow, Richard E Thompson, Lee-Jen Wei, et al.BMJ Open|August 24, 2024
Systematic review protocol to determine the most effective pharmacological and non-pharmacological interventions for the management of acute methamphetamine toxicitySumantra Monty Ghosh, Janice Y Kung, David Crockford, et al.Journal of Psychiatric Research|June 13, 2021
Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trialsKyle A McKee, Amira Hmidan, Candice E Crocker, et al.Schizophrenia Research|November 1, 2024
Quality indicators for schizophrenia care: A scoping reviewJennifer C Anderson, Dallas P Seitz, David Crockford, et al.Pageof 4